We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 3,993

Tax Court Rejects IRS Argument that Corporate Taxpayer Failed to File Valid Return
  • McDermott Will & Emery
  • USA
  • September 13 2017

The issue of whether a valid tax return has been filed usually comes up in the context of individuals. One common situation involves taxpayers who


Sixth Circuit Hits Federal Government with $450,000 in Legal Fees to be Paid to FCA Defendant Under the Equal Access to Justice Act
  • McDermott Will & Emery
  • USA
  • September 11 2017

In an unusual ruling on August 18, 2017, the US Court of Appeals for the Sixth Circuit reversed the Middle District of Tennessee's denial of the


Interpretation of Means-Plus-Function Claim Limitations
  • McDermott Will & Emery
  • USA
  • May 25 2017

Addressing claim construction issues in connection with "means-plus-function" limitations, the US Court of Appeals for the Federal Circuit affirmed


DOJ Prosecution of Heir Location Service Providers Dismissed on Statute of Limitations Grounds
  • McDermott Will & Emery
  • USA
  • September 11 2017

On August 28, 2017, the US District Court for the District of Utah issued two rulings in United States v. Kemp & Assoc., Inc. (Kemp) of note for


Home Is Where the Non-Infringement Is
  • McDermott Will & Emery
  • USA
  • August 29 2017

The US Court of Appeals for the Seventh Circuit affirmed a summary judgment ruling that the plaintiff did not offer sufficient proof that the


SEC sues private company and its CEO for fraud related to buyback program involving employee stock bonus plan
  • McDermott Will & Emery
  • USA
  • February 29 2012

On December 12, 2011, the U.S. Securities and Exchange Commission (SEC) filed suit in the U.S. District Court for the Southern District of Florida against Stiefel Laboratories, a family-owned dermatological products business that was acquired by GlaxoSmithKline (GSK) in 2009, and against Charles Stiefel, the company’s former chairman and CEO


Raise a Glass to the Single Dispositive DuPont Factor
  • McDermott Will & Emery
  • USA
  • July 26 2016

The US Court of Appeals for the Federal Circuit upheld a decision by the Trademark Trial and Appeal Board (TTAB) reiterating its determination that a


Section 256 inventorship claim does not accrue until the patent issues
  • McDermott Will & Emery
  • USA
  • December 27 2012

Addressing challenges to inventorship under 35 U.S.C. 256, the U.S. Court of Appeals for the Federal Circuit reversed a district court's grant of


Obviousness Does Not Require Absolute Predictability
  • McDermott Will & Emery
  • USA
  • August 29 2017

Addressing the issue of obviousness, the US Court of Appeals for the Federal Circuit affirmed three inter partes re-examination decisions of the


Indirect Patent Infringement Can Be Based on Willful Blindness and Circumstantial Evidence
  • McDermott Will & Emery
  • USA
  • July 26 2016

In a case remanded by the Supreme Court of the United States "for further consideration in light of Commil" (IP Update, Vol. 18, No. 6), the US Court